L.E.K.’s Take on China Medtech: Optimistic Macro View, Short-Term Hit Hard Stephen Sunderland Read more
Related Practice MedTech Despite the COVID-19 lockdown, Stephen Sunderland foresees limited disruption 07102020100744
Video / Webinar Healthcare On the Cusp of a Cure: Preparing Asia Pacific for the Precision Era December 18, 2025
Case Study Life Sciences & Pharma Developing and Operationalizing Omnichannel Capabilities in the Pharmaceutical Market November 12, 2025
Executive Insights Life Sciences & Pharma Indonesia’s Retail Pharmacy Landscape: Why Global Investors Should Take a Closer Look October 16, 2025
Video / Webinar Healthcare Australia's Private Healthcare Sector: Strategic Outlook and Opportunities October 6, 2025
Executive Insights Life Sciences & Pharma When Is It Too Late? Drivers of Commercial Performance for Late Entrants in Biopharma April 28, 2025
